Despite ongoing bipartisan prompts from Congress, doctors and veterans, frustrated veterans across the United States are still widely starved of medical cannabis access.
Lack of research means that...
Some 40 million U.S. adults are believed to suffer from anxiety, whereas major depressive disorder affects some 17.3 million American adults.
Despite the prevalence of mental health conditions, typical...
The latest analysis from progressive statistical surveying firm Market Research Future has provided some updated insights into the worldwide medical cannabis market.
Analysts responsible for carrying...
A new study suggests that a cultivation site at the University of Mississippi – which has been certified by the Drug Enforcement Administration (DEA) to grow research-grade cannabis for the last few...
The cannabis that is being grown at the University of Mississippi for research purposes has been found to be more similar to hemp than dispensary cannabis, a new study found. This is currently the only...
At the grand old age of 90, Raphael Mechoulam is still making waves in the cannabis industry.
Author of CBD: What Does the Science Say? and winner of the Harvey Prize in Human Health, "the father...
A new study, published in Frontiers in Psychiatry this past September hypothesized that medical cannabis may provide symptomatic relief for people who suffer from depression and anxiety.
The study's...
According to a study conducted by a leading cannabis surveyor for the federal U.S. government, state-level legalization has further dented the Drug Enforcement Administration’s (DEA) opportunities to...
A new study finds that legalizing cannabis helps reduce crime rates. The study found that previous research into crime rates and legalization has been flawed due to the fact they were based on FBI data...
The DEA is proposing drastically increasing the amount of cannabis and psychedelics that are produced for medical research. The psychedelics it’s proposing producing at higher levels include psilocybin,...
Research published by a team of pharmacologists at the University of Sydney suggests that cannabis may possess potent extracts suitable for the treatment of epilepsy.
In a groundbreaking report, the...
On September 27, pioneer in the cannabis edibles market Azuca unveiled the findings of its “Americans and Cannabis Consumption Survey.” The survey explores consumer behavior and habits pertaining to...
